BGI-Shenzhen Acquires Complete Genomics

BGI-Shenzhen has acquired Nasdaq-listed Complete Genomics via an all cash tender offer, followed by a short form merger. The deal closed on March 18, 2013. It has been reported as the first time a Chinese company has successfully acquired a US public company. O’Melveny & Myers represented BGI-Shenzhen.

DealsNorth AmericaUSBriefs